Recall

Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter

Headline as published by U.S. Food and Drug Administration (Recalls).

Read at U.S. Food and Drug Administration (Recalls)

ROCHESTER, MI– September 18, 2026 –Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose or stopper materia

From U.S. Food and Drug Administration (Recalls)’s feed

Topics

Tags are matched against PI Data Hub’s own index of firms, bar associations, conferences and the JPML’s active MDL list. The quoted words are the exact text that produced each tag. Nothing on this page is written by AI. Sources and method